Ceragenix Pharmaceuticals

FDA Approvals: Integrated Insulin Pump/Glucose Monitoring System
Medscape News - April 18, 2006 The US Food and Drug Administration (FDA) has approved an integrated insulin pump and continuous glucose monitoring system for the management of type 1 and type 2 diabetes mellitus; 3 fetoscopy instrument sets for the treatment of

Ceragenix to Present at Rodman & Renshaw Third Annual Global
dBusinessNews.com - DENVER -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix"), a biopharmaceutical company focused on infectious disease and dermatology, today announced that Steven Porter, Chairman and CEO of Ceragenix, will present at the Rodman & Renshaw 3rd Annual

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006
Genetic Engineering News - Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo. For in-depth information about the event visit http://www.rodmanandrenshaw.com/Conferences.asp?CID=conf9. Below are profiles from Rodman & Renshaw 3rd

business Colorado business, 5/2
Denver Post - Tattered Cover Book Store announced Monday it is seeking original designs for a T-shirt intended to celebrate its move to the Lowenstein Theatre redevelopment project on East Colfax Avenue. The bookstore has been a fixture in Cherry Creek North for